Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection

被引:38
|
作者
Zheng, Hongmei [1 ]
Zhan, Yuting [1 ]
Zhang, Yuting [1 ]
Lin, Sile [1 ]
Lu, Junmi [1 ]
Yang, Yang [1 ]
Wen, Qiuyuan [1 ]
Fan, Songqing [1 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha 410011, Hunan, Peoples R China
来源
CANCER MEDICINE | 2019年 / 8卷 / 16期
基金
中国国家自然科学基金;
关键词
biomarker; G3BP1; nonsmall cell lung cancer; p-AKT; prognosis; YB1; EPITHELIAL-MESENCHYMAL TRANSITION; GTPASE-ACTIVATING PROTEIN; POTENTIAL TARGETS; BINDING PROTEIN-1; SIGNALING PATHWAY; BREAST-CANCER; YB-1; PROMOTES; CARCINOMA; OVEREXPRESSION;
D O I
10.1002/cam4.2579
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose G3BP1 is an RNA-binding protein and plays roles in regulating signaling pathway. YB-1 is a DNA/RNA binding protein encoded by YBX1 gene. Phosphorylated AKT (p-AKT) acts as a pivotal molecule in PI3K/AKT pathway. YB-1 drives stress granules (SGs) formation by activating G3BP1 translation under diverse conditions. SGs are involved in many different metabolic and signaling pathways which may include PI3K/AKT/mTOR. So far, there has been no report on the relationship between expression of G3BP1, p-AKT, and YB1 and clinicopathological features/prognosis in surgically resected nonsmall cell lung cancer (NSCLC) patients. Methods In this study, data from TCGA (The Cancer Genome Atlas) were downloaded to investigate the mRNA expression of G3BP1 and YB1 (YBX1) and their correlation in NSCLC. Also, expression of G3BP1, YB1, and p-AKT proteins was studied using immunohistochemistry in tissue microarrays of NSCLC and in noncancerous lung tissues. Results We found that the mRNA expression of G3BP1 and YB1 was higher in NSCLC tissues (both P .05), and G3BP1 was positively correlated with YB1 in mRNA level (r = .399, P < .001). Also, expression of G3BP1, YB1, and p-AKT proteins was higher in NSCLC tissues (all P < .05). And higher expression of G3BP1 and YB1 proteins was seen in patients with clinical stage II and III compared with stage I (both P < .05). Besides, expression of G3BP1 protein had a positive correlation with YB1 and p-AKT (both P < .05). Moreover, overall survival was shorter in patients with overexpression of G3BP1, YB1, and p-AKT proteins (all P < .05). Multivariate analysis confirmed that overexpression of G3BP1 protein was an independent poorer prognostic factor for NSCLC patients (P = .039). Conclusion G3BP1 may play a crucial role in activating PI3K/AKT/mTOR pathway. G3BP1 might be served as a novel prognostic biomarker for surgically resected NSCLC patients, which afforded new insights into the study on the mechanism and therapy of NSCLC.
引用
收藏
页码:6894 / 6903
页数:10
相关论文
共 15 条
  • [1] Elevated HSP90 associates with expression of HIF-1α and p-AKT and is predictive of poor prognosis in nasopharyngeal carcinoma
    Feng, Juan
    Xie, Guiyuan
    Zhan, Yuting
    Lu, Junmi
    Xu, Lina
    Fan, Songqing
    Wang, Weiyuan
    HISTOPATHOLOGY, 2019, 75 (02) : 202 - 212
  • [2] Co-expression of PD-L1 and HIF-1α predicts poor prognosis in Patients with Non-small Cell Lung Cancer after surgery
    Zheng, Hongmei
    Ning, Yue
    Zhan, Yuting
    Liu, Sile
    Yang, Yang
    Wen, Qiuyuan
    Fan, Songqing
    JOURNAL OF CANCER, 2021, 12 (07): : 2065 - 2072
  • [3] Mitotic arrest deficient-like 1 is correlated with poor prognosis in small-cell lung cancer after surgical resection
    Li, Dandan
    Meng, Qingwei
    Zhang, Huijuan
    Feng, Ting
    Liu, Meiyan
    Cai, Li
    TUMOR BIOLOGY, 2016, 37 (04) : 4393 - 4398
  • [4] Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer
    Yang, Fang
    Gao, Yina
    Geng, Jingshu
    Qu, Di
    Han, Qiuyue
    Qi, Jiping
    Chen, Gongyan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (12): : 2846 - 2854
  • [5] Downregulation of HDPR1 Is Associated With Poor Prognosis and Affects Expression Levels of p120-Catenin and β-Catenin in Nonsmall Cell Lung Cancer
    Yang, Zhi-Qiang
    Zhao, Yue
    Liu, Yang
    Zhang, Jun-Yi
    Zhang, Sheng
    Jiang, Gui-Yang
    Zhang, Peng-Xin
    Yang, Lan-He
    Liu, Di
    Li, Qing-Chang
    Wang, En-Hua
    MOLECULAR CARCINOGENESIS, 2010, 49 (05) : 508 - 519
  • [6] Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma
    Cui, Yan
    Cui, Chun-ai
    Yang, Zhao-ting
    Ni, Wei-dong
    Jin, Yu
    Xuan, Yan-hua
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2017, 102 (02) : 347 - 353
  • [7] MicroRNA-1301-3p promotes the progression of non-small cell lung cancer by targeting Thy-1 and predicts poor prognosis of patients
    Xu, Ling
    Ni, Na
    Gao, Haiyang
    Hu, Pengbo
    ONCOLOGY LETTERS, 2021, 21 (04)
  • [8] High expression of monocarboxylate transporter 4 (MCT 4), but not MCT 1, predicts poor prognosis in patients with non-small cell lung cancer
    Tong, Ying-Hui
    Hu, Xiao-Ping
    Xiang, Xue-Ping
    Fang, Luo
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (03) : 1336 - +
  • [9] Transforming growth factor-β1 and α-smooth muscle actin in stromal fibroblasts are associated with a poor prognosis in patients with clinical stage I-IIIA nonsmall cell lung cancer after curative resection
    Chen, Yongbing
    Zou, Li
    Zhang, Yongsheng
    Chen, Yuanyuan
    Xing, Pengfei
    Yang, Wentao
    Li, Feng
    Ji, Xiaoqing
    Liu, Fengjv
    Lu, Xueguan
    TUMOR BIOLOGY, 2014, 35 (07) : 6707 - 6713
  • [10] Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non-small cell lung cancer (NSCLC) via the PI3K/AKT pathway
    Zhu, Weiliang
    Shi, Lin
    Gong, Yuxin
    Zhuo, Lin
    Wang, Siyun
    Chen, Shaobing
    Zhang, Bei
    Ke, Bin
    THORACIC CANCER, 2022, 13 (07) : 1027 - 1039